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Previewsby its prior use in autologous bone
marrow stem cell transplantation. Two
broadly different perspectives are recog-
nizable, focused on cardiac myocytes,
as above, or more typically on bone
marrow-derived cells’ mobilization and
homing to injured hearts. Alone, G-CSF
impairs homing of bone marrow cells to
the heart, perhaps by inhibiting the migra-
tory response to SDF-1; by contrast,
G-CSF plus a CD26/dipeptidylpeptidase
IV inhibitor that elevates SDF1 levels
improved these cells’ recruitment to the
heart, augmenting vascularization, pump
function, and survival (Zaruba et al.,
2009). Cardiac-resident progenitor cells
are a third potential target, as indicated
by the fact that G-CSF may enhance the
number of cardiac Sca-1+ cells (Brunner
et al., 2008; cf. Harada et al., 2005). Is
G-CSFR functionally coupled in the
endogenous cardiac progenitor/stem
cells resident in adult human hearts? Are
salutary effects of G-CSF on the adult
heart mediated in part by these cells?
Might G-CSF be used to drive cardiopoie-
sis by adult cardiac progenitor cells, in
culture or in situ?
Optimization of any potential cardio-
poietin must take into account the effects
on proliferation as well as lineage
commitment. Proliferation can occur in
embryonic cardiomyocytes (Olson and
Schneider, 2003), and Shimoji et al.(2010) localized the proliferation evoked
by G-CSF to Mef2+ cells, Nkx2.5+ cells,
and a-actinin+ cells. However, suscepti-
bility to G-CSF was largely lost by E12.5.
It remains to be learned whether other
hypoplastic cardiac phenotypes impinge
on this axis, e.g., through precocious
differentiation, whether cardiac progeni-
tors from both heart fields require
G-CSF, and whether the effect of G-CSF
is entirely myocyte autonomous.
The unexpected cardiac-lethal pheno-
type of gcsfr3/ mice differs from the
original report of this knockout line, which
had no premature lethality and was said to
develop normally (Liu et al., 1996). This
inconsistency might be explained by the
differing genetic background (ultimately
backbred to C57Bl/6), but leads to the
more general consideration, how many
other essential cardiopoietins have been
overlooked in ostensibly conclusive
models? How might heart-forming factors
best be identified in the future? Comple-
mentary, higher-throughput approaches
to detect novel cardiopoietins have begun
to include robotic screens in stem cells
and other systems (Sadek et al., 2008).
Along with other ‘‘high-bandwidth’’ ap-
proaches like saturation mutagenesis,
these experimental platforms hold the
promise of defining workable triggers for
cardiac muscle creation, beyond the
insights obtainable in stem cells or modelCell Stem Ceorganisms manipulating just one factor or
pathway at a time, on an artisanal scale.REFERENCES
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In a recent paper inNature, Vierbuchen et al. (2010) show that fibroblasts can be directly converted into func-
tional neurons by defined factors. This finding sheds new light on the biology underlying cell-fate restrictions
and might offer a new avenue for studying neurological diseases.The finding that differentiated somatic
cells such as fibroblasts can be reprog-
rammed into induced pluripotent stemcells (iPSCs) by four (or even fewer)
transcription factors (TFs) revolutionized
the understanding of cellular plasticityand provided a novel tool to study devel-
opmental processes and mechanisms
of human disease (Takahashi et al.,ll 6, March 5, 2010 ª2010 Elsevier Inc. 189
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Figure 1. Directing Cell Fate with Ectopic Master Gene Expression
Waddington’s epigenetic landscape with uncommitted pluripotent cells at the
summit and distinct, fully differentiated cells at the bottom of the valleys pre-
dicted that the ball (here standing for cell lineage) could only roll downhill.
However, with iPSC technology differentiated cells can be reprogrammed
into a pluripotent cell that can in turn give rise to most (if not all) tissues,
e.g., brain cells (gray arrows). Lineages within germline boundaries can also
be crossed with single or multiple-factor expression (directed differentiation,
black arrow) (e.g., Jessberger et al., 2008 or Zhou et al., 2008). Vierbuchen
et al. now showed that iN technology with three defined TFs can convert cells
from one lineage into another, even across germline boundaries (blue arrow).
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are high expectations that
iPSC-derived cells might
be a promising source for
patient-specificcell-replace-
ment therapies (Hanna
et al., 2007).
Vierbuchen and col-
leagues now take the
concept of cell-fate reprog-
ramming one step further
and show that fully differen-
tiated embryonic and post-
natal fibroblasts can be effi-
ciently converted into
functional neurons (called
iN cells) without the detour
of an uncommitted pluripo-
tent cell (Vierbuchen et al.,
2010). They did so by
producing lentiviral vectors
expressing 19 different TFs
that had previously been
implicated in neuronal fate
determination and cellular
reprogramming and tested
them for their ability toinduce neuronal properties after transduc-
tion of fibroblasts. To screen for a large
number of TF combinations, they used
fibroblasts that were isolated from a trans-
genic mouse expressing a GFP reporter
under the neuronally restricted tau
promoter (tauEGFP). Using this approach,
they found that the proneural bHLH TF
Ascl1 (also called Mash1) on its own was
sufficient to induce neuronal properties in
cells derived from fibroblasts, although at
a low rate. They went on to determine the
minimal number of TFs required for effi-
cient fate conversionand neuronalmatura-
tion of iN cells and identified two TFs that
together with Ascl1 rapidly and efficiently
converted fibroblasts into iN cells: Brn2,
previously identified as a key gene during
embryonic neurogenesis regulating notch
signaling, and Myt1l, associated with
epigenetic modifications in neural cells. In
fact, up to 20% of all fibroblasts targeted
with viruses expressing Ascl1, Brn2, and
Myt1l expressed neuronal markers within
several days after viral transduction.
Importantly, Vierbuchen and colleagues
used electrophysiological recordings to
prove that iN cells are indeed capable of
firing action potentials and forming func-
tional synapses as soon as 12 days after
fate conversion when plated with other
iN cells or cocultured with embryonic190 Cell Stem Cell 6, March 5, 2010 ª2010 Eneurons. When analyzing the neuronal
subtype generated by iN technology, Vier-
buchen et al. found that the majority of
cells differentiated into excitatory, gluta-
matergic neurons (which is surprising
given the predominant role of Ascl1 for
the generation of GABAergic, inhibitory
cells or oligodendrocytic cells in vivo;
Casarosa et al., 1999; Jessberger et al.,
2008).
What are the implications of the direct
conversion of fibroblasts into neurons
both for our understanding of the basic
biology underlying cell-fate specification
and for potential therapeutic applications
with iN cells?
A former concept regarding the mecha-
nisms underlying cell specification was
that cells, which have terminally differenti-
ated, are bound in their cell fate because
of irreversible epigenetic modifications
that prevent the transcription of genes
specific to other cell lineages. The devel-
opment of iPSC technology has chal-
lenged this concept by showing that in
principle every cell retains the potential to
dedifferentiate into a pluripotent ground
state by overexpression of a few TFs
(Figure 1). However, reprogramming of
somatic cells into an iPSC involves a thor-
ough eradication of epigenetic marks,
thereby allowing the cell to ‘‘start all overlsevier Inc.again’’ with an at least partially
naive chromatin (Maherali
et al., 2007). The findings by
Vierbuchen et al. show that
directed conversion from one
differentiated cell type into
another (in this case fibroblasts
into neurons) with only three
TFs can be achieved very
quickly (within days) and effi-
ciently, without going back to
an uncommitted pluripotent
cell state. Future studies
will have to analyze whether
the three TFs used merely
impose the neuronal pheno-
type over the fibroblast pheno-
type, which could still be
hidden within the cell, e.g., on
an epigenetic level. Alterna-
tively, the three TFs could acti-
vate transcriptional networks
required for neuronal differenti-
ation and at the same time
erase the epigenetic signature
of fibroblasts while converting
them into neurons.The finding by Vierbuchen et al. sup-
ports the notion that there are powerful
master genes controlling cell fate. This
has previously been implied by showing
that a single TF (or the combination of
a few) was sufficient to direct the fate of
cells from one lineage into another, even
in vivo (Figure 1) (Davis et al., 1987; Jess-
berger et al., 2008; Zhou et al., 2008).
However, the important advancement of
the current study is that previous studies
converted cell fates within germ-layer
boundaries (e.g., fibroblasts into muscle;
exocrine pancreas cells into b-cells).
Vierbuchen et al. now converted cells
from the mesoderm (fibroblasts) into neu-
rons that originate from the ectoderm
(Figure 1). With the novel finding of cell-
type conversion, it is clear that despite
extensive and functionally important
regulation of gene transcription by chro-
matin modifications or noncoding RNAs,
a handful of genes can control the fate
of cells even across germline boundaries.
Thus, pushing the right button (or as in the
Vierbuchen study, three buttons) can
have dramatic effects on cell fate and
differentiation. In this context, the iN tech-
nology might together with classical
developmental neurobiology, embryonic
stem cell (ESC) research, and iPSC tech-
nology be useful in identifying
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entiation and specification.
Anticipating that iN technology also
works for human cells (which awaits con-
firmation), patient-specific iN cells might
provide a novel platform for disease
modeling and might also be a source for
cell-replacement therapies. This is in
principle already possible with iPSC strat-
egies. However, a major roadblock pre-
venting the clinical use of iPSCs for thera-
peutic transplantation is the danger of
transplanting single undifferentiated cell
clones prone to cancerous growth (Miura
et al., 2009). This substantial side effect of
iPSCs should be nonexistent in iN cells,
even though long-term transplantation
studies will have to formally show this. In
addition, it seems reasonable to specu-
late that the ‘‘trick’’ of conversion not
only works for neurons but also for many
other cell types such as liver or pancreas,
which could also be useful for disease
modeling or cell replacement.
The findings presented by Vierbuchen
et al. offer a novel technology and source
to generate neurons, but the real chal-lenge in replacing lost neurons in most
degenerative human diseases will be to
identify the mechanisms that regulate
and orchestrate the meaningful and func-
tional integration of transplanted cells, so
that replacing neurons can truly take over
the function of injured areas. In addition, it
could turn out that neuronal diversity even
within the same neuronal lineage, which
seems to be a cardinal feature of neuronal
circuitries at least in the primate brain,
cannot be achieved without context-
dependent cues that are missing in the
culture dish (Muotri and Gage, 2006). Be
that as it may, the study by Vierbuchen
et al. adds a novel and important piece
to the existing toolbox that will be instru-
mental to understanding and potentially
treating human neurological diseases.REFERENCES
Casarosa, S., Fode, C., and Guillemot, F. (1999).
Development 126, 525–534.
Davis, R.L., Weintraub, H., and Lassar, A.B. (1987).
Cell 51, 987–1000.Cell Stem CeHanna, J., Wernig, M., Markoulaki, S., Sun, C.W.,
Meissner, A., Cassady, J.P., Beard, C., Brambrink,
T., Wu, L.C., Townes, T.M., and Jaenisch, R.
(2007). Science 318, 1920–1923.Jessberger, S., Toni, N., Clemenson, G.D., Jr.,
Ray, J., and Gage, F.H. (2008). Nat. Neurosci. 11,
888–893.Maherali, N., Sridharan, R., Xie, W., Utikal, J.,
Eminli, S., Arnold, K., Stadtfeld, M., Yachechko,
R., Tchieu, J., Jaenisch, R., et al. (2007). Cell
Stem Cell 1, 55–70.
Miura, K., Okada, Y., Aoi, T., Okada, A., Takahashi,
K., Okita, K., Nakagawa, M., Koyanagi, M.,
Tanabe, K., Ohnuki, M., et al. (2009). Nat. Biotech-
nol. 27, 743–745.
Muotri, A.R., and Gage, F.H. (2006). Nature 441,
1087–1093.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M.,
Ichisaka, T., Tomoda, K., and Yamanaka, S.
(2007). Cell 131, 861–872.
Vierbuchen, T., Ostermeier, A., Pang, Z.P.,
Kokubu, Y., Su¨dhof, T.C., and Wernig, M. (2010).
Nature, in press. Published online January 27,
2010. 10.1038/nature08797.
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J.,
and Melton, D.A. (2008). Nature 455, 627–632.Niche Today, Gone Tomorrow—Progenitors Create
Short-Lived Niche for Stem Cell SpecificationMelanie Issigonis1 and Erika Matunis1,*
1Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
*Correspondence: matunis@jhmi.edu
DOI 10.1016/j.stem.2010.02.010
Establishing tissue-specific adult stem cells during organogenesis is important for maintenance of tissue
homeostasis throughout the lifetime of the organism. In a recent study in Science, Mathur et al. (2010)
describe how progenitor cells in the Drosophila larval midgut create a temporary niche to maintain stem
cell fate during development.Stem cells are generally thought to reside
in niches, or specialized local microenvi-
ronments, which prevent differentiation
(Fuller and Spradling, 2007). Although
both stem cells and their niches arise
during development, the mechanismsgov-
erning their specification are poorly under-
stood (Slack, 2008). In a recent report in
Science, the Ohlstein lab provides an inter-
esting glimpse into this process in theDrosophila midgut by showing that stem
cell precursors (known as adult midgut
progenitors [AMPs]) specify their own tran-
sient ‘‘niche’’ (peripheral cells [PCs]) during
morphogenesis (Mathur et al., 2010).
The Drosophila adult midgut is an
epithelial monolayer composed of ab-
sorptive enterocytes (ECs) interspersed
with secretory enteroendocrine (ee) cells.
Although this tissue had long beenconsidered quiescent, groundbreaking
work in 2006 revealed that it is con-
stantly renewed by a pool of intestinal
stem cells (ISCs). ISCs divide asymmetri-
cally to produce both ISCs and daugh-
ters (enteroblasts [EBs]) that differentiate
into ECs or ee cells in a Notch-depen-
dent manner (Micchelli and Perrimon,
2006; Ohlstein and Spradling, 2006)
(Figure 1C).ll 6, March 5, 2010 ª2010 Elsevier Inc. 191
